Otis Worldwide heads into its July 22 Q2 earnings release with a rare split in its options and short interest signals — call buyers are turning aggressive just as shorts quietly accumulate.
The options story is striking. The put/call ratio collapsed to 0.57 on Thursday, almost 1.3 standard deviations below its 20-day average of 0.83 — the most call-heavy positioning of the past several weeks. That stands in sharp contrast to the prior two weeks, where the PCR ran above 1.0 every single session. The shift suggests traders rotated hard into calls on the day the stock fell 2.1% to $73.45, either as a speculative bet on a positive surprise or as a hedge against existing short positions.
Short interest tells a more cautious underlying story. Bears have added meaningfully — SI has climbed 34% over the past month to roughly 4.2% of the free float, with the bulk of that build concentrated in late June through mid-July. The borrow market remains easy despite the accumulation: availability is extremely loose at over 3,300% (roughly 22 shares available for every short already placed), and the cost to borrow is just 0.51%, despite having risen 44% over the past month. In practice, shorts face no structural squeeze pressure. The short score has drifted up to 39.6 from around 37.6 three weeks ago — notable movement but not an extreme reading.
The analyst community frames a genuine fundamental debate heading into the print. Bulls point to the 22% year-over-year jump in modernization order intake and a backlog up 16%, arguing that the service segment's compounding growth justifies patience through a soft new-equipment cycle. Bears are harder to dismiss: Otis has cut full-year guidance for four consecutive quarters, Q2 organic sales fell 2%, and the stock is already down sharply from February levels when it traded near $92. Most analyst activity on the name is from April — when RBC trimmed its target to $105, Barclays cut to $77, and Wolfe Research downgraded to Peer Perform — with the consensus mean price target of around $95 now sitting nearly 30% above the current price. That gap reflects a Street that still believes in the long-term thesis but has repeatedly been wrong about the timing of a recovery. Forward EPS momentum ranks in the 91st percentile on a 12-month basis, yet the 30- and 90-day EPS momentum scores sit at 37 and 29 respectively — the Street is revising down in the near term even as longer-horizon estimates hold up.
Recent earnings reactions at Otis have been consistently soft beyond the first session. The May 2026 print saw a 2.1% one-day drop and a 3.9% five-day decline; the April 2026 release managed a small 0.8% bounce on day one before fading 2.9% over the following week. Tuesday's report will test whether management's H2 acceleration narrative — the linchpin of the bull case — shows any early evidence of materializing, or whether guidance gets trimmed for a fifth time.
See the live data behind this article on ORTEX.
Open OTIS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
